Skip to Main content Skip to Navigation
Journal articles

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Abstract : In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference where key issues in the management of these 2 diseases were considered by a global panel of experts. Areas addressed included renal pathology, clinical phenotype and assessment, genetic drivers of disease, acquired drivers of disease, and treatment strategies. In order to help guide clinicians who are caring for such patients, recommendations for best treatment strategies were discussed at length, providing the evidence base underpinning current treatment options. Knowledge gaps were identified and a prioritized research agenda was proposed to resolve outstanding controversial issues.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-01793663
Contributor : Anthony Herrada <>
Submitted on : Wednesday, May 16, 2018 - 5:42:59 PM
Last modification on : Friday, September 18, 2020 - 2:35:01 PM

Links full text

Identifiers

Citation

Timothy Goodship, H Terence Cook, Fadi Fakhouri, Fernando Fervenza, Veronique Fremeaux-Bacchi, et al.. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney International, Nature Publishing Group, 2017, 91 (3), pp.539 - 551. ⟨10.1016/j.kint.2016.10.005⟩. ⟨hal-01793663⟩

Share

Metrics

Record views

279